SLC44A1

Choline transporter-like protein 1 · Q8WWI5 · SLC44A1 on Sugi Atlas →

0 patent compounds predicted against SLC44A1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC44A1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacogenomic Evaluation of Antihypertensive Responses PHASE4COMPLETED
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) PHASE2COMPLETED
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia PHASE1/PHASE2RECRUITING
Tolerability of Enteral NAC in Infants PHASE1NOT_YET_RECRUITING
Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease nanNOT_YET_RECRUITING
Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants nanCOMPLETED
Egg Intake, Metabolic Outcomes and Choline Levels nanRECRUITING
Human Requirements for the Nutrient Choline nanCOMPLETED
Bile Acid Effects in Fetal Arrhythmia Study nanUNKNOWN
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients. nanCOMPLETED
Choline to Improve Malnutrition and Enhance Cognition nanRECRUITING
Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus nanCOMPLETED
Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study nanRECRUITING
Effect of Maternal Choline Intake on Choline Status and Health Biomarkers During Pregnancy and Lactation nanCOMPLETED
Stem Cell Study of Genetics and Drug Addiction nanCOMPLETED
Choline Dose Ranging in Postmenopausal Women nanCOMPLETED
Nutritional Prevention of Exertional Muscle Dysfunction nanCOMPLETED
Choline and Brain Functioning in Postmenopausal Women nanCOMPLETED
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer nanUNKNOWN
18F-FDOPA PET in Neuroendocrine Tumours nanNO_LONGER_AVAILABLE
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin nanUNKNOWN
Pharmacogenetics in Non Small Cell Lung Cancer nanUNKNOWN
The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux nanCOMPLETED
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation nanRECRUITING
Renal Transporters After Renal Transplantation nanUNKNOWN
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC44A1 binder may also engage these)

ProteinNameSimilarity
Q6X893 1.000 Q6X893 →
Q8VII6 1.000 Q8VII6 →
Q6IR74 1.000 Q6IR74 →
A5PK40 0.975 A5PK40 →
Q8N4M1 0.972 Q8N4M1 →
Q8IWA5 0.971 Q8IWA5 →
Q810F1 0.970 Q810F1 →
Q5R5L9 0.969 Q5R5L9 →
F1S584 0.967 F1S584 →
B4F795 0.965 B4F795 →
Q8BY89 0.964 Q8BY89 →
A5D7H3 0.964 A5D7H3 →
B0JZD0 0.960 B0JZD0 →
Q6AY92 0.955 Q6AY92 →
Q6IP59 0.955 Q6IP59 →
D3ZXD8 0.953 D3ZXD8 →
E1BD52 0.952 E1BD52 →
A5PMW0 0.951 A5PMW0 →
Q9QZ71 0.950 Q9QZ71 →
B1AZA5 0.950 B1AZA5 →
Q5RA57 0.949 Q5RA57 →
Q5ZMP3 0.949 Q5ZMP3 →
Q9TU72 0.949 Q9TU72 →
Q9H330 0.949 Q9H330 →
Q9UBH6 0.948 Q9UBH6 →
A7XZ53 0.948 A7XZ53 →
Q9R031 0.948 Q9R031 →
Q8WVP7 0.948 Q8WVP7 →
Q5RET6 0.947 Q5RET6 →
Q17QL9 0.947 Q17QL9 →